We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

XOMA Announces License Agreement with Novo Nordisk

News   Dec 04, 2015

 
XOMA Announces License Agreement with Novo Nordisk
 
 
Advertisement
 

RELATED ARTICLES

Experts Respond to Reported Death of COVID-19 Vaccine Trial Participant

News

News has emerged from Brazil that a participant of the Phase III clinical trial investigating the COVID-19 vaccine, ChAdOX1, has died.

READ MORE

Glutathione Precursor Improves Conditions Associated With Premature Aging in HIV Patients

News

An open-label clinical trial found that a glutathione precursor, GlyNAC, reverses premature aging in people with HIV.

READ MORE

Scientists Begin To Unravel the Complexity of DNA Enhancers

News

In an attempt to learn more about DNA enhancers, the Crocker group from EMBL Heidelberg performed an extensive study, published in Nature, on a specific enhancer in the model organism Drosophila melanogaster, a species of fruit fly.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE